ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,746, issued on April 15, was assigned to SUVEN LIFE SCIENCES Ltd. (Hyderabad-Telangana, India).

"Pyrrolo[1,2-b-2-pyridazinone compounds as 5-HT4 receptor agonists" was invented by Ramakrishna Nirogi (Hyderabad, India), Anil Karbhari Shinde (Hyderabad, India), Abdul Rasheed Mohammed (Hyderabad, India), Vinod Kumar Goyal (Hyderabad, India), Santosh Kumar Pandey (Hyderabad, India), Vijay Sidram Benade (Hyderabad, India), Venkatesh Goura (Hyderabad, India) and Venkateswarlu Jasti (Hyderabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pyrrolo[1,2-b]-2-pyridazinone compounds of formula (I), or their isotopic forms...